---
category: news
title: "A16z-Backed AI Biotech Startup Genesis Therapeutics Raises $200M"
excerpt: "A large round to a startup working at the intersection of AI and biotech is perhaps not surprising, given that the two sectors have led our list of very large funding deals this year."
publishedDateTime: 2023-08-21T16:47:00Z
originalUrl: "https://news.crunchbase.com/ai-robotics/a16z-backed-ai-biotech-startup-genesis-therapeutics-raises-200m/"
webUrl: "https://news.crunchbase.com/ai-robotics/a16z-backed-ai-biotech-startup-genesis-therapeutics-raises-200m/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: news.crunchbase
  domain: crunchbase.com

topics:
  - AI
  - AI in Robotics

images:
  - url: "https://news.crunchbase.com/wp-content/uploads/Biotech_Privacy.jpg"
    width: 900
    height: 506
    isCached: true

related:
  - title: "Genesis raises $200m for AI drug discovery engine"
    excerpt: "The latest round takes the total raised by Burlingame, California-based Genesis to $280 million and will be used to transition to a clinical-stage drug developer, according to the company. Its first round brought in $52 million in 2020."
    publishedDateTime: 2023-08-21T21:19:00Z
    webUrl: "https://pharmaphorum.com/news/genesis-raises-200m-ai-drug-discovery-engine"
    type: article
    provider:
      name: pharmaphorum
      domain: pharmaphorum.com
    quality: 39
    images:
      - url: "https://pharmaphorum.com/sites/default/files/2023-08/DNA_molecules_internal_organs.jpg"
        width: 900
        height: 600
        isCached: true
  - title: "Genesis Therapeutics Rakes In $200M For AI-Powered Drug Discovery"
    excerpt: "The startup’s physics-centric AI platform is what sets it apart from its competitors, Sklaroff argued. Genesis has “deep expertise” in physics-based methods for computational chemistry, which the company combines with its proprietary machine learning ..."
    publishedDateTime: 2023-08-22T00:11:00Z
    webUrl: "https://medcitynews.com/2023/08/biotech-ai-physics-drug-discovery-venture-capital/"
    type: article
    provider:
      name: MedCity News
      domain: medcitynews.com
    quality: 37
    images:
      - url: "https://medcitynews.com/uploads/2017/01/GettyImages-488634096.jpg"
        width: 683
        height: 512
        isCached: true
  - title: "Andreessen co-leads $200M investment in biotech startup Genesis Therapeutics"
    excerpt: "Genesis Therapeutics closed a $200 million Series B financing round co-led by venture firm Andreessen Horowitz, the AI-driven drug discovery startup said Monday."
    publishedDateTime: 2023-08-21T20:37:00Z
    webUrl: "https://www.mmm-online.com/home/channel/andreessen-co-leads-200m-investment-in-biotech-startup-genesis-therapeutics/"
    type: article
    provider:
      name: MM&M
      domain: mmm-online.com
    quality: 19
    images:
      - url: "https://www.mmm-online.com/wp-content/uploads/sites/2/2023/08/GettyImages-1243702915.jpg"
        width: 1024
        height: 683
        isCached: true
  - title: "An­dreessen Horowitz-backed start­up lands $200M for AI-based drug dis­cov­ery"
    excerpt: "Genesis Therapeutics, a startup using artificial intelligence to design small molecule drugs, has raised $200 million in Series B financing — one of the largest rounds for an AI-focused biotech this year."
    publishedDateTime: 2023-08-21T12:00:00Z
    webUrl: "https://endpts.com/genesis-therapeutics-raises-200m-for-ai-drug-discovery-based-on-stanford-research/"
    type: article
    provider:
      name: ENDPOINTS NEWS
      domain: endpts.com
    quality: 13
  - title: "AI drug discovery company Genesis Therapeutics scores $200 million in new funding"
    excerpt: "A Stanford University spinout, promising a new era of AI-guided drug discovery ... Genesis has no clinical data – in fact, it’s not officially saying yet when it will even start clinical trials, let alone which conditions it is targeting – but ..."
    publishedDateTime: 2023-08-22T15:21:00Z
    webUrl: "https://www.bizjournals.com/sanfrancisco/news/2023/08/22/genesis-therapeutics-200-million-funding.html"
    type: article
    provider:
      name: The Business Journals
      domain: bizjournals.com
    quality: 12

secured: "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;pcuhlhrrto/M4mnfGBG4TQ=="
---

